Ran Frenkel

2014

In 2014, Ran Frenkel earned a total compensation of $6.5M as Executive Vice President, Worldwide Development Operations at Karyopharm Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$15,611
Option Awards$6,392,000
Salary$64,157
Other$10,097
Total$6,481,865

Frenkel received $6.4M in option awards, accounting for 99% of the total pay in 2014.

Frenkel also received $15.6K in non-equity incentive plan, $64.2K in salary and $10.1K in other compensation.

Rankings

In 2014, Ran Frenkel's compensation ranked 1,076th out of 13,032 executives tracked by ExecPay. In other words, Frenkel earned more than 91.7% of executives.

ClassificationRankingPercentile
All
1,076
out of 13,032
92nd
Division
Manufacturing
391
out of 4,966
92nd
Major group
Chemicals And Allied Products
129
out of 1,686
92nd
Industry group
Drugs
101
out of 1,365
93rd
Industry
Pharmaceutical Preparations
90
out of 1,043
91st
Source: SEC filing on April 7, 2015.

Frenkel's colleagues

We found four more compensation records of executives who worked with Ran Frenkel at Karyopharm Therapeutics in 2014.

2014

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

2014

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2014

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2014

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

News

In-depth

You may also like